Attention Deficit Hyperactivity Disorder (ADHD): Clinical Trials

7 trials for Attention Deficit Hyperactivity Disorder (ADHD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 terminated, 1 unknown. 7 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Recruiting 1, Terminated 1, Unknown 1
Phase 32Completed 1, Recruiting 1

Follow Attention Deficit Hyperactivity Disorder (ADHD): new trials by email Literature Review of Attention Deficit Hyperactivity Disorder (ADHD) trials Research Report on Attention Deficit Hyperactivity Disorder (ADHD)

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
EB-1020 (Centanafadine) 164.4 mg, EB-1020 (Centanafadine) 328.8 mg, Placebo - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2 / Phase 3RecruitingOtsuka Pharmaceutical Co., Ltd.6302025-04-302026-10-23
The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Oral CBD oil enriched with terpenes, Oral Placebo - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2UnknownBazelet Nehushtan LtD.1202024-08-222024-08-23
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
Functional Magnetic Resonance Imaging (fMRI), Magnetic Resonance Spectroscopy (MRS), Point Subtraction Aggression Paradigm (PSAP) Task - Attention Deficit Hyperactivity Disorder (ADHD), Impulsive Aggression
Phase 2TerminatedSupernus Pharmaceuticals, Inc.72019-05-302025-05-02
Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder
SPD489 - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2CompletedShire242015-04-152021-06-08
Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits
ADHD Medication, Omega-3 Fatty Acids - Attention Deficit Hyperactivity Disorder (ADHD), Deficient Emotional Self-Regulation (DESR)
Phase 2CompletedMassachusetts General Hospital22012-02-012018-10-23
Classroom-based Distance Intervention for Teachers of Children With Attention Deficit Hyperactivity Disorder
Teacher Help for ADHD - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2CompletedDalhousie University1162012-02-012014-03-28
Train Your Brain and Exercise Your Heart? Advancing the Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
Neurofeedback, Exercise, methylphenidate - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2 / Phase 3CompletedR. van Mourik1122010-06-012015-12-09

Narrower conditions

Attention Deficit Disorder with Hyperactivity (7)  ·  Motor Activity (1)  ·  Spasm (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (7)  ·  Mental Disorders (7)  ·  Neurodevelopmental Disorders (7)  ·  Behavior (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

Methylphenidate (2)  ·  1-(naphthalen-2-yl)-3-azabicyclo(3.1.0)hexane (1)  ·  Adderall (1)  ·  Amphetamine (1)  ·  Atomoxetine Hydrochloride (1)  ·  Biofeedback, Psychology (1)  ·  Dexmethylphenidate Hydrochloride (1)  ·  Dextroamphetamine (1)  ·  Exercise (1)  ·  Fatty Acids, Omega-3 (1)  ·  Lisdexamfetamine Dimesylate (1)  ·  Magnetic Resonance Imaging (1)  ·  Neurofeedback (1)  ·  Positron-Emission Tomography (1)  ·  Saposins (1)

Sponsors

Bazelet Nehushtan LtD. (1)  ·  Dalhousie University (1)  ·  Massachusetts General Hospital (1)  ·  Otsuka Pharmaceutical Co., Ltd. (1)  ·  R. van Mourik (1)  ·  Shire (1)  ·  Supernus Pharmaceuticals, Inc. (1)

Countries

United States (3)  ·  Canada (1)  ·  Israel (1)  ·  Japan (1)  ·  Netherlands (1)

Top investigators

Craig Surman, MD (1)  ·  Jaap Oosterlaan, Professor (1)  ·  Matitiahu Berkovitch, MD (1)  ·  Nezihe Elik, PhD (1)  ·  Nobuhito Sanada (1)  ·  Penny V Corkum, PhD (1)  ·  Rosa van Mourik, PhD (1)

Results publications

PMID 26748531, PMID 26771913, PMID 27631143, PMID 27866283, PMID 29098467, PMID 32233956, PMID 32304847